Articles

Sarepta finally gets some good news: A patient death wasn’t its DMD drug’s fault.

Sarepta Therapeutics’ stock was soaring Tuesday after the FDA recommended lifting the pause on the company’s Duchenne muscular dystrophy drug, but analysts worry it will take time for patients and doctors to feel safe using it.

Gen Z doesn’t need your approval, but it does need good advice. My new column, Dollar Signs, is here to help.

Instead of relying on data points to decode Gen Z — or, really, anyone starting their financial journey — I want to speak directly to them.

Tariffs will push Procter & Gamble’s prices higher, but maker of consumer products is wary of the discounting frenzy

Procter & Gamble Co. on Tuesday said it would raise prices on around 25% of the products it sells in the U.S. due to tariffs. But as higher prices keep shoppers cautious, executives at the maker of consumer products including Tide and Bounty argued that cheaper products don’t guarantee longer-term success.

GDP is ready to pop, but not because the U.S. economy is popping

Here’s how to read the second-quarter report on gross domestic product.

Comcast could see its heaviest internet subscriber losses ever. Then what?

A Bernstein analyst says Comcast executives will need to address their efforts to stabilize the broadband subscriber base and whether these are showing initial success.

Trump’s tariffs head back to court: What to know

Trade deals like the U.S.-European Union agreement could be at risk from a case winding its way through courts in the U.S.

The bad-news-is-good-news stock market

The stock market is more overvalued than at almost any time in U.S. history.

How stock-market investors should trade what could be a historic Fed dissent over interest rates on Wednesday

These are not “normal times” when it comes to the Federal Reserve and monetary policy.

Nvidia’s stock is rising as confidence builds around this key number

The chip company is waiting to sell its H20 chips in China again, which a Mizuho analyst said will help the case for its earnings per share to reach $7 next fiscal year.

Looking for the stock market’s next big winners? Just look for these three numbers.

While investors today seem gripped by a mania for growth stocks, they are really just gripped by momentum. They are buying assets that have already gone up in the hope that they will keep going up.

Consumer confidence rebounds slightly in July on easing inflation fears and higher stock prices

“Consumers are rattled,” one analyst noted, “and rattled consumers spend less than confident consumers.”

Job openings decline and hiring tapers off due to trade wars. The good news? Layoffs are still low.

Job openings fell in June to close to a postpandemic low as trade wars discouraged businesses from hiring, but the rate of layoffs also stood near a record low, in a good sign for the broader U.S. economy.
1 162 163 164 165 166 2,371